Yükleniyor…
Buradaki her şirket aynı beş büyüme ve nakit üretimi kontrolünden geçirildi. Bu, sektörü bugün bildirdiği hâliyle anlatır — hangisinin alınacağını değil.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | $138,7B | $547,02 | 35,22 | $13B | %30,7 |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | $101,3B | $959,45 | 21,18 | $16,9B | %28,5 |
| MRNA | Moderna, Inc. | C- | $100,6B | $248,70 | — | $2,5B | -%110,5 |
| ARGX | ARGENX SE | notsuz | $60,5B | $977,29 | 49,94 | — | — |
| ONC | BEONE MEDICINES LTD. | A+ | $48B | $420,06 | 53,85 | $6,6B | %13,9 |
| RPRX | Royalty Pharma plc | C+ | $40,1B | $69,97 | 45,73 | $2,6B | %25,7 |
| RVMD | Revolution Medicines, Inc. | F | $39,1B | $180,66 | — | $0,00 | — |
| ROIV | ROIVANT SCIENCES LTD. | B- | $30,3B | $41,85 | — | $41,1M | -%838,2 |
| INSM | INSMED INC | C- | $26,5B | $120,64 | — | $1,5B | -%39,9 |
| INCY | INCYTE CORPORATION | C | $24,9B | $122,23 | 65,01 | $6B | %6,7 |
| BNTX | BioNTech SE | F | $22B | $87,64 | — | $2,7B | -%60,9 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | B+ | $21,4B | $159,80 | 68,58 | $3,7B | %71,3 |
| NCNA | NUCANA PLC | notsuz | $19,5B | $0,94 | — | — | — |
| EXEL | EXELIXIS, INC. | A+ | $17,3B | $70,71 | 21,17 | $2,5B | %35,5 |
| ASND | Ascendis Pharma A/S | D | $16,1B | $259,10 | — | $1,2B | -%21,8 |
| JAZZ | Jazz Pharmaceuticals plc | A | $15,9B | $248,18 | 80,84 | $4,7B | %4,4 |
| BBIO | BridgeBio Pharma, Inc. | B | $15,5B | $79,53 | — | $945,5M | -%60,7 |
| SMMT | Summit Therapeutics Inc. | notsuz | $13,3B | $16,63 | — | — | — |
| AKTX | Akari Therapeutics Plc | notsuz | $11,9B | $7,62 | — | — | — |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | $11,6B | $101,69 | 25,36 | $1,8B | %26,9 |
| KYMR | KYMERA THERAPEUTICS, INC. | F- | $11,5B | $134,90 | — | $102,2M | -%341,8 |
| TECH | BIO-TECHNE Corp | A+ | $11,4B | $72,78 | 66,77 | $1,2B | %14,0 |
| BMRN | BioMarin Pharmaceutical Inc | B | $11,3B | $58,32 | — | $3,7B | -%0,5 |
| PCVX | VAXCYTE, INC. | notsuz | $10,9B | $68,62 | — | — | — |
| SYRE | SPYRE THERAPEUTICS, INC. | D | $10,1B | $106,77 | — | $0,00 | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | B- | $10,1B | $432,64 | — | $1,4B | -%10,9 |
| TGTX | TG THERAPEUTICS, INC. | A+ | $9,9B | $65,75 | 98,13 | $897,8M | %11,8 |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | $9,7B | $346,46 | — | $0,00 | — |
| KRYS | Krystal Biotech, Inc. | A+ | $9,2B | $308,82 | 41,90 | $470M | %47,9 |
| PTGX | PROTAGONIST THERAPEUTICS, INC. | A+ | $8,8B | $134,76 | 28,61 | $551,7M | %62,0 |
| CORT | CORCEPT THERAPEUTICS INC | A+ | $8,2B | $74,52 | 58,68 | $963,6M | %16,8 |
| CYTK | CYTOKINETICS, INCORPORATED | D | $8,2B | $58,52 | — | $113,3M | -%686,6 |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | $7,8B | $149,20 | — | $865,3M | -%18,2 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | $7,8B | $112,18 | — | $280,7M | -%69,0 |
| TWST | Twist Bioscience Corporation | C- | $7,7B | $122,71 | — | $459,4M | -%28,3 |
| IMVT | Immunovant, Inc. | notsuz | $7,7B | $37,04 | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | notsuz | $7,3B | $107,10 | — | — | — |
| ABVX | Abivax S.A. | notsuz | $7,2B | $91,37 | — | — | — |
| IBRX | IMMUNITYBIO, INC. | C | $7,1B | $6,67 | — | $182,6M | -%607,8 |
| CAI | CARIS LIFE SCIENCES, INC. | A | $7B | $24,50 | 14,76 | $1B | %9,2 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | F- | $7B | $49,36 | — | $450,8M | -%160,6 |
| KOD | Kodiak Sciences Inc. | notsuz | $6,9B | $109,23 | — | — | — |
| MANE | Veradermics, Inc | notsuz | $6,6B | $156,30 | — | — | — |
| CGON | CG Oncology, Inc. | F- | $6,5B | $72,66 | — | $6,2M | -%3.851,1 |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | C | $6,3B | $317,16 | 137,90 | $253,8M | %20,3 |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | $6,2B | $94,64 | — | $670,8M | -%134,8 |
| BLTE | Belite Bio, Inc | notsuz | $6,1B | $155,94 | — | — | — |
| ERAS | ERASCA, INC. | notsuz | $5,9B | $16,80 | — | — | — |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F- | $5,7B | $46,54 | — | $570K | -%72.563,2 |
| PTCT | PTC Therapeutics, Inc. | D | $5,4B | $64,87 | — | $1,2B | -%9,2 |
| EWTX | Edgewise Therapeutics, Inc. | notsuz | $5,2B | $47,58 | 5,82 | — | — |
| COGT | Cogent Biosciences, Inc. | notsuz | $5,1B | $29,39 | — | — | — |
| DNTH | Dianthus Therapeutics, Inc. | F- | $5B | $89,24 | — | $2M | -%9.927,5 |
| TVTX | TRAVERE THERAPEUTICS, INC. | F- | $5B | $52,06 | — | $651M | -%18,7 |
| DFTX | Definium Therapeutics, Inc. | notsuz | $4,7B | $34,46 | — | — | — |
| IONS | IONIS PHARMACEUTICALS, INC. | F- | $4,7B | $28,31 | — | $960,1M | -%56,9 |
| GPCR | Structure Therapeutics Inc. | notsuz | $4,5B | $20,98 | — | — | — |
| CRSP | CRISPR THERAPEUTICS AG | F- | $4,5B | $45,89 | — | $25,2M | -%1.812,1 |
| TNGX | TANGO THERAPEUTICS, INC. | F | $4,4B | $25,71 | — | $0,00 | — |
| RLAY | RELAY THERAPEUTICS, INC. | D- | $4,4B | $19,71 | — | $10,4M | -%2.837,0 |
| ZLAB | ZAI LAB LIMITED | F- | $4,3B | $26,43 | — | $441,7M | -%44,9 |
| XENE | Xenon Pharmaceuticals Inc. | F | $4,1B | $42,09 | — | $0,00 | — |
| IRON | Disc Medicine, Inc. | notsuz | $4B | $87,11 | — | — | — |
| ABCL | AbCellera Biologics Inc. | C- | $3,9B | $11,94 | — | $67,9M | -%218,5 |
| TARS | TARSUS PHARMACEUTICALS, INC. | B- | $3,8B | $76,71 | — | $682,2M | -%102,9 |
| ELVN | ENLIVEN THERAPEUTICS, INC. | notsuz | $3,8B | $51,17 | — | — | — |
| DBVT | DBV TECHNOLOGIES S.A. | F- | $3,7B | $11,91 | — | $3,8M | -%5.405,3 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | $3,7B | $8,08 | — | $379M | -%58,2 |
| PBLS | Parabilis Medicines, Inc. | notsuz | $3,7B | $29,64 | — | — | — |
| VKTX | VIKING THERAPEUTICS, INC. | F | $3,6B | $28,43 | — | $0,00 | — |
| LEGN | Legend Biotech Corp | C- | $3,6B | $19,54 | — | $1,1B | -%22,0 |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | B | $3,6B | $28,36 | 135,05 | $508,7M | %5,9 |
| VRDN | Viridian Therapeutics, Inc./DE | F- | $3,5B | $31,24 | — | $26,3M | -%1.724,1 |
| GMAB | Genmab A/S | B+ | $3,4B | $53,87 | 3,50 | $3,9B | %21,0 |
| DYN | Dyne Therapeutics, Inc. | notsuz | $3,4B | $17,98 | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D | $3,3B | $9,73 | — | $890,8M | %3,8 |
| ACAD | ACADIA PHARMACEUTICALS INC. | B+ | $3,2B | $18,35 | 8,66 | $1,2B | %30,1 |
| DNLI | Denali Therapeutics Inc. | F | $3,2B | $19,73 | — | $0,00 | — |
| IDYA | IDEAYA Biosciences, Inc. | F- | $3,2B | $32,69 | — | $36,5M | -%1.149,6 |
| CELC | CELCUITY INC. | notsuz | $3,2B | $64,31 | — | — | — |
| VCEL | VERICEL CORPORATION | A | $3B | $59,40 | 92,81 | $324,2M | %10,3 |
| XNCR | Xencor, Inc | D- | $3B | $39,99 | — | $200,5M | -%58,8 |
| ADMA | ADMA BIOLOGICS, INC. | B+ | $2,9B | $13,19 | 17,13 | $519,2M | %35,1 |
| MBX | MBX Biosciences, Inc. | notsuz | $2,9B | $57,49 | — | — | — |
| RCUS | Arcus Biosciences, Inc. | F- | $2,7B | $18,80 | — | $100M | -%453,0 |
| BEAM | Beam Therapeutics Inc. | F- | $2,7B | $25,79 | — | $146,6M | -%73,9 |
| NAMS | NewAmsterdam Pharma Company N.V. | D- | $2,5B | $20,75 | — | $25,9M | -%789,9 |
| PVLA | Palvella Therapeutics, Inc. | notsuz | $2,4B | $163,83 | — | — | — |
| CLDX | Celldex Therapeutics, Inc. | F- | $2,4B | $30,14 | — | $158K | -%195.608,9 |
| SEPN | Septerna, Inc. | F- | $2,3B | $48,54 | — | $96,3M | -%61,3 |
| BHVN | Biohaven Ltd. | notsuz | $2,3B | $15,20 | — | — | — |
| IMNM | Immunome Inc. | F | $2,3B | $19,07 | — | $0,00 | — |
| VIR | Vir Biotechnology, Inc. | C- | $2,2B | $13,12 | — | $302,8M | -%61,0 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | $2,2B | $3,59 | — | $68,2M | -%697,1 |
| PHVS | Pharvaris N.V. | notsuz | $2,2B | $34,12 | — | — | — |
| VERA | Vera Therapeutics, Inc. | notsuz | $2,2B | $30,44 | — | — | — |
| LKFT | GALAPAGOS NV | D | $2,2B | $33,38 | 6,14 | $1,2B | %28,9 |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | $2,2B | $16,21 | 7,08 | $321,7M | %97,7 |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | notsuz | $2,1B | $50,53 | — | — | — |
| TRVI | TREVI THERAPEUTICS, INC. | notsuz | $2,1B | $14,82 | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | notsuz | $2,1B | $21,76 | — | — | — |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | B+ | $2B | $34,23 | 11,30 | $989,4M | %18,1 |
| MAZE | MAZE THERAPEUTICS, INC. | notsuz | $2B | $36,72 | — | — | — |
| ZYME | ZYMEWORKS INC. | F+ | $2B | $29,03 | 55,83 | $266M | %16,3 |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | $2B | $7,70 | — | $213M | -%30,8 |
| FTRE | Fortrea Holdings Inc. | C | $2B | $20,38 | — | $2,7B | -%2,6 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | $2B | $32,83 | — | $140,8M | -%264,8 |
| ZBIO | Zenas BioPharma, Inc. | F- | $1,9B | $28,68 | — | $10M | -%5.418,1 |
| BRVE | Braveheart Bio, Inc. | notsuz | $1,9B | $20,83 | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | notsuz | $1,9B | $14,38 | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | notsuz | $1,8B | $39,23 | — | — | — |
| STOK | Stoke Therapeutics, Inc. | F- | $1,8B | $27,72 | — | $28,2M | -%862,1 |
| SRPT | SAREPTA THERAPEUTICS, INC. | C | $1,8B | $16,68 | — | $2B | -%5,9 |
| NRIX | NURIX THERAPEUTICS, INC. | A+ | $1,8B | $16,33 | 7,10 | $701,9M | %42,0 |
| MESO | MESOBLAST LIMITED | C- | $1,8B | $13,66 | — | $65,4M | -%144,3 |
| GENB | Generate Biomedicines, Inc. | notsuz | $1,7B | $13,49 | — | — | — |
| ABSI | ABSCI CORP | F- | $1,7B | $10,08 | — | $1,6M | -%8.050,7 |
| QURE | uniQure N.V. | F- | $1,7B | $24,61 | — | $20,2M | -%1.154,8 |
| SLS | SELLAS Life Sciences Group, Inc. | notsuz | $1,7B | $8,43 | — | — | — |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | $1,7B | $16,70 | — | $730M | -%71,8 |
| PGEN | PRECIGEN, INC. | C | $1,7B | $4,71 | 47,10 | $156,9M | %15,6 |
| NVAX | NOVAVAX, INC. | F | $1,6B | $9,97 | — | $411,6M | -%18,6 |
| IMCR | Immunocore Holdings plc | F- | $1,6B | $31,64 | — | $429,3M | -%7,5 |
| NTLA | INTELLIA THERAPEUTICS, INC. | D- | $1,6B | $11,41 | — | $52,9M | -%805,7 |
| RAPP | Rapport Therapeutics, Inc. | notsuz | $1,6B | $27,00 | — | — | — |
| NBTX | Nanobiotix S.A. | C- | $1,6B | $33,00 | — | $36,4M | -%73,5 |
| NUVB | Nuvation Bio Inc. | C- | $1,5B | $4,28 | — | $201,7M | -%67,4 |
| OCUL | OCULAR THERAPEUTIX, INC | F- | $1,5B | $6,64 | — | $50,4M | -%648,6 |
| ANAB | ANAPTYSBIO, INC. | C+ | $1,5B | $48,73 | 8,49 | $237,6M | %77,6 |
| TYRA | TYRA BIOSCIENCES, INC. | notsuz | $1,4B | $20,93 | — | — | — |
| LBRX | LB Pharmaceuticals Inc | notsuz | $1,4B | $44,65 | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | notsuz | $1,4B | $23,24 | — | — | — |
| MLYS | MINERALYS THERAPEUTICS, INC. | notsuz | $1,4B | $16,18 | — | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | D- | $1,4B | $15,19 | — | $96,6M | -%193,4 |
| AVLN | Avalyn Pharma Inc. | notsuz | $1,4B | $31,57 | — | — | — |
| TSHA | Taysha Gene Therapies, Inc. | F- | $1,4B | $4,27 | — | $5,5M | -%2.844,6 |
| MNKD | MannKind Corporation | D | $1,3B | $4,18 | — | $413,4M | -%18,1 |
| INVA | INNOVIVA, INC. | C+ | $1,3B | $18,86 | 9,43 | $438,3M | %44,1 |
| INBX | INHIBRX BIOSCIENCES, INC. | F- | $1,3B | $90,63 | — | $1,3M | -%10.629,3 |
| OMER | OMEROS CORP | notsuz | $1,3B | $18,14 | 10,55 | — | — |
| NKTR | Nektar Therapeutics | F- | $1,3B | $38,43 | — | $52,2M | -%339,7 |
| URGN | UroGen Pharma Ltd. | C | $1,3B | $26,07 | — | $250,3M | -%26,3 |
| ANRO | Alto Neuroscience, Inc. | notsuz | $1,2B | $31,15 | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | notsuz | $1,2B | $14,05 | — | — | — |
| VOR | Vor Biopharma Inc. | notsuz | $1,2B | $20,10 | 0,07 | — | — |
| GHRS | GH Research PLC | notsuz | $1,2B | $19,22 | — | — | — |
| SGP | SpyGlass Pharma, Inc. | notsuz | $1,2B | $34,90 | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | notsuz | $1,1B | $13,50 | — | — | — |
| VSTM | Verastem, Inc. | F- | $1,1B | $9,09 | — | $100,3M | -%178,4 |
| SPTX | Seaport Therapeutics, Inc. | notsuz | $1,1B | $21,26 | — | — | — |
| SVRA | Savara Inc. | notsuz | $1,1B | $4,99 | — | — | — |
| JBIO | Jade Biosciences, Inc. | notsuz | $1,1B | $16,56 | — | — | — |
| ODTX | Odyssey Therapeutics, Inc. | notsuz | $1B | $20,94 | — | — | — |
| CRVS | Corvus Pharmaceuticals, Inc. | notsuz | $968,8M | $11,49 | — | — | — |
| AKTS | Aktis Oncology, Inc. | notsuz | $950,8M | $17,04 | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | $936,9M | $12,98 | — | $92M | -%217,8 |
| SLN | Silence Therapeutics plc | D- | $934,1M | $19,77 | — | $615K | -%8.361,1 |
| ORIC | ORIC PHARMACEUTICALS, INC. | notsuz | $930,8M | $8,98 | — | — | — |
| MGTX | MeiraGTx Holdings plc | A | $930,7M | $9,69 | 13,65 | $397,5M | %19,9 |
| PHAR | Pharming Group N.V. | A | $929,4M | $13,25 | 331,13 | $376,1M | %0,8 |
| IMTX | Immatics N.V. | notsuz | $898,3M | $6,70 | — | — | — |
| LTGO | Latigo Biotherapeutics, Inc. | notsuz | $897,7M | $13,54 | — | — | — |
| GLUE | Monte Rosa Therapeutics, Inc. | F- | $880,1M | $10,30 | — | $70,3M | -%186,2 |
| ANNX | ANNEXON, INC. | notsuz | $861,1M | $4,19 | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | $856,4M | $9,59 | — | $289,7M | -%72,3 |
| ALMS | Alumis Inc. | F- | $856,2M | $6,62 | — | $7,2M | -%5.844,5 |
| SLDB | Solid Biosciences Inc. | notsuz | $849,4M | $7,61 | — | — | — |
| RIGL | RIGEL PHARMACEUTICALS INC | B+ | $837,7M | $44,49 | 2,77 | $288,2M | %106,6 |
| LXRX | Lexicon Pharmaceuticals, Inc. | D- | $828,1M | $1,86 | — | $38,5M | -%161,8 |
| SGMT | Sagimet Biosciences Inc. | notsuz | $814,3M | $11,41 | — | — | — |
| AURA | AURA BIOSCIENCES, INC. | notsuz | $792M | $7,61 | — | — | — |
| ARDX | ARDELYX, INC. | C- | $785,5M | $3,13 | — | $468,2M | -%11,8 |
| PRME | Prime Medicine, Inc. | D- | $779M | $4,30 | — | $4,6M | -%4.056,4 |
| IVA | Inventiva S.A. | F | $776,8M | $4,02 | — | $5M | -%7.899,6 |
| ATTO | Attovia Therapeutics, Inc. | notsuz | $766,8M | $16,78 | — | — | — |
| JANX | Janux Therapeutics, Inc. | C- | $755,6M | $12,35 | — | $23,3M | -%428,7 |
| ACHV | Achieve Life Sciences, Inc. | notsuz | $747,1M | $6,79 | — | — | — |
| OABI | OMNIAB, INC. | B | $743,9M | $5,10 | — | $40,2M | -%108,1 |
| CGEM | CULLINAN THERAPEUTICS, INC. | notsuz | $735,6M | $11,33 | — | — | — |
| NVCT | NUVECTIS PHARMA, INC. | notsuz | $721,5M | $20,98 | — | — | — |
| CLYM | Climb Bio, Inc. | notsuz | $719,5M | $12,25 | — | — | — |
| KURA | Kura Oncology, Inc. | C- | $710,2M | $7,73 | — | $79,3M | -%369,3 |
| CADL | CANDEL THERAPEUTICS, INC. | notsuz | $705,1M | $9,22 | — | — | — |
| ZVRA | Zevra Therapeutics, Inc. | B+ | $704,8M | $11,85 | 9,95 | $147,8M | %52,8 |
| OLMA | OLEMA PHARMACEUTICALS, INC. | notsuz | $703,5M | $8,03 | — | — | — |
| AVBP | ARRIVENT BIOPHARMA, INC. | notsuz | $699,3M | $13,52 | — | — | — |
| APMD | Apnimed, Inc. | notsuz | $698,6M | $16,78 | — | — | — |
| BCAX | BICARA THERAPEUTICS INC. | notsuz | $698,4M | $10,52 | — | — | — |
| ACRS | Aclaris Therapeutics, Inc. | F- | $689,2M | $4,35 | — | $6,4M | -%1.244,1 |
| SANA | Sana Biotechnology, Inc. | notsuz | $689,2M | $2,30 | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | $689M | $10,76 | — | $0,00 | — |
| WVE | WAVE LIFE SCIENCES, INC. | F- | $672,6M | $3,41 | — | $70,9M | -%296,9 |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | F- | $664,8M | $10,26 | — | $130,8M | -%192,0 |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | $651,8M | $11,21 | — | $0,00 | — |
| GERN | GERON CORP | notsuz | $644,2M | $1,00 | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | notsuz | $619,2M | $8,66 | — | — | — |
| ABUS | ARBUTUS BIOPHARMA CORP | D+ | $595,5M | $3,89 | 3,44 | $181,5M | %121,2 |
| CBIO | Crescent Biopharma, Inc. | D- | $573,9M | $14,76 | — | $15M | -%727,6 |
| RGNX | REGENXBIO Inc. | F- | $560,1M | $8,47 | — | $153,9M | -%113,9 |
| ENTX | ENTERA BIO LTD. | F | $559,9M | $3,22 | — | $0,00 | — |
| DMAC | DIAMEDICA THERAPEUTICS INC. | notsuz | $521,2M | $9,66 | — | — | — |
| NGNE | Neurogene Inc. | F | $518,8M | $25,06 | — | $0,00 | — |
| STTK | Shattuck Labs, Inc. | F | $512,3M | $5,03 | — | $0,00 | — |
| VALN | Valneva SE | F- | $511,9M | $5,90 | — | $174,7M | -%73,7 |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | $510,5M | $6,28 | — | $274,9M | -%30,2 |
| AVTX | AVALO THERAPEUTICS, INC. | F- | $492,1M | $8,51 | — | $59K | -%150.259,3 |
| GYRE | Gyre Therapeutics, Inc. | F- | $491,8M | $4,27 | — | $108,1M | -%33,9 |
| JSPR | Jasper Therapeutics, Inc. | notsuz | $491M | $14,76 | — | — | — |
| MDXG | MIMEDX GROUP, INC. | F | $483M | $3,31 | — | $303,7M | -%6,3 |
| MNPR | Monopar Therapeutics Inc. | F | $482,3M | $71,86 | — | $0,00 | — |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | $474,6M | $6,03 | — | $31,2M | -%182,5 |
| RLMD | RELMADA THERAPEUTICS, INC. | notsuz | $473,1M | $4,44 | — | — | — |
| CTMX | CytomX Therapeutics, Inc. | F- | $465,4M | $2,14 | — | $14M | -%609,0 |
| ASMB | Assembly Biosciences, Inc. | B- | $454,9M | $22,34 | — | $72,3M | -%15,4 |
| ARVN | ARVINAS, INC. | C- | $452,5M | $6,91 | — | $275,3M | -%3,5 |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | D- | $448,8M | $8,74 | — | $52,7M | -%45,4 |
| YDES | YD Bio Limited | D | $440,3M | $6,22 | — | $596,8K | -%1.392,6 |
| TECX | TECTONIC THERAPEUTIC, INC. | notsuz | $438,9M | $22,00 | — | — | — |
| KRSA | Korsana Biosciences, Inc. | F | $427,5M | $31,61 | — | $1,9M | -%3.098,7 |
| INDP | Indaptus Therapeutics, Inc. | notsuz | $426,4M | $3,20 | — | — | — |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | notsuz | $422,9M | $1,95 | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | $418,2M | $8,09 | 17,59 | $231,8M | %10,3 |
| IRD | Opus Genetics, Inc. | F- | $415,6M | $4,30 | — | $7,9M | -%1.726,7 |
| LYEL | Lyell Immunopharma, Inc. | F- | $414,5M | $16,86 | — | $15K | -%1.701.066,7 |
| CRMD | CORMEDIX INC. | B+ | $413,9M | $5,31 | 2,59 | $462,2M | %13,8 |
| OCS | Oculis Holding AG | notsuz | $397,6M | $7,61 | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | F- | $397,1M | $3,95 | — | $122,1M | -%163,6 |
| KARD | Kardigan, Inc. | notsuz | $396,1M | $15,72 | — | — | — |
| RZLT | Rezolute, Inc. | notsuz | $395,6M | $4,09 | — | — | — |
| ALEC | Alector, Inc. | B+ | $388,6M | $2,61 | 7,46 | $173,5M | %23,9 |
| CCCC | C4 Therapeutics, Inc. | D- | $378,2M | $2,88 | — | $32,3M | -%282,2 |
| ALT | ALTIMMUNE, INC. | D- | $375,4M | $1,93 | — | $41K | -%254.522,0 |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | $373,5M | $10,65 | — | $59,2M | -%5,5 |
| EDIT | EDITAS MEDICINE, INC. | B- | $367,3M | $2,38 | — | $49,8M | -%145,0 |
| PEPG | PEPGEN INC. | notsuz | $365M | $5,27 | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | notsuz | $360,2M | $6,65 | — | — | — |
| ANL | Adlai Nortye Ltd. | C | $347,1M | $10,86 | — | $5M | -%710,6 |
| IMUX | Immunic, Inc. | notsuz | $346,9M | $8,16 | — | — | — |
| FTH | Faeth Therapeutics, Inc. | notsuz | $345M | $13,35 | — | — | — |
| PROK | ProKidney Corp. | F- | $340,2M | $1,13 | — | $775K | -%13.326,7 |
| AVIR | Atea Pharmaceuticals, Inc. | notsuz | $338,1M | $4,21 | — | — | — |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | $337,7M | $11,60 | — | $65,3M | -%96,9 |
| GALT | GALECTIN THERAPEUTICS INC. | notsuz | $332,3M | $3,30 | — | — | — |
| BNTC | BENITEC BIOPHARMA INC. | D | $329,6M | $9,45 | — | $0,00 | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | $328,8M | $3,22 | — | $17M | -%474,7 |
| AUTL | AUTOLUS THERAPEUTICS PLC | C- | $327,6M | $1,23 | — | $137,4M | -%186,4 |
| AGEN | AGENUS INC | D | $327,1M | $7,23 | 10,95 | $133,9M | %23,0 |
| OCGN | OCUGEN, INC. | F | $325,1M | $0,96 | — | $4,8M | -%1.367,6 |
| TTRX | Turn Therapeutics Inc. | notsuz | $324,7M | $10,62 | — | — | — |
| KYTX | Kyverna Therapeutics, Inc. | notsuz | $323,1M | $5,11 | — | — | — |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | $321,2M | $8,04 | — | $0,00 | — |
| SCTX | SCRIBE THERAPEUTICS INC. | notsuz | $319,3M | $16,86 | — | — | — |
| IPSC | Century Therapeutics, Inc. | C- | $317,8M | $1,75 | — | $109,2M | -%90,5 |
| MPLT | MapLight Therapeutics, Inc. | notsuz | $317M | $7,47 | — | — | — |
| CABA | CABALETTA BIO, INC. | notsuz | $315M | $1,46 | — | — | — |
| EVMN | Evommune, Inc. | D- | $313,9M | $8,65 | — | $10M | -%1.130,7 |
| ALLO | Allogene Therapeutics, Inc. | C- | $313,1M | $0,90 | — | $6,9M | -%2.513,9 |
| VERU | VERU INC. | notsuz | $308,9M | $2,11 | — | — | — |
| VOGX | Vogenx, Inc. | notsuz | $308,5M | $20,77 | — | — | — |
| NAUT | NAUTILUS BIOTECHNOLOGY, INC. | notsuz | $306,3M | $2,41 | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | $302,5M | $3,79 | — | $22,4M | -%269,7 |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | $286,1M | $3,75 | — | $0,00 | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | notsuz | $284,6M | $2,74 | — | — | — |
| LCTX | Lineage Cell Therapeutics, Inc. | F | $284,5M | $1,13 | — | $10,8M | %16,2 |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | $280,7M | $12,87 | — | $0,00 | — |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | $279,3M | $3,10 | — | $0,00 | — |
| INO | INOVIO PHARMACEUTICALS, INC. | C- | $277,2M | $1,48 | — | $298,9K | -%23.798,9 |
| QTTB | Q32 Bio Inc. | B | $275,3M | $9,20 | 2,65 | $53,7M | %60,0 |
| RCKT | Rocket Pharmaceuticals, Inc. | D | $271,1M | $2,47 | — | $0,00 | — |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | $268,3M | $9,31 | — | $30,5M | -%285,9 |
| PLX | PROTALIX BIOTHERAPEUTICS, INC. | A+ | $264,3M | $3,14 | 12,54 | $84,7M | %24,3 |
| CAMP | CAMP4 Therapeutics Corporation | B- | $261,7M | $4,17 | — | $5,3M | -%2.276,3 |
| BCYC | Bicycle Therapeutics plc | C- | $258,2M | $3,69 | — | $83,5M | -%169,8 |
| CUVL | CLINUVEL PHARMACEUTICALS LIMITED | C+ | $256,7M | $5,09 | 11,07 | $64,3M | %36,0 |
| DTIL | PRECISION BIOSCIENCES INC | D- | $255,3M | $9,14 | — | $45M | -%85,6 |
| LXEO | Lexeo Therapeutics, Inc. | notsuz | $252,3M | $3,08 | — | — | — |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | $250,9M | $4,15 | — | $229,3M | -%119,9 |
| CTNM | Contineum Therapeutics, Inc. | notsuz | $249M | $10,78 | — | — | — |
| IMRX | Immuneering Corporation | notsuz | $245,3M | $3,79 | — | — | — |
| IRLA | Quince Therapeutics, Inc. | notsuz | $242,4M | $39,53 | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | notsuz | $237,3M | $16,17 | — | — | — |
| ACIU | AC IMMUNE SA | D- | $229,9M | $2,26 | — | $4,5M | -%1.903,0 |
| IKT | INHIBIKASE THERAPEUTICS, INC. | F | $227,9M | $1,63 | — | $0,00 | — |
| ELDN | Eledon Pharmaceuticals, Inc. | notsuz | $217M | $2,67 | — | — | — |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | $213,8M | $5,46 | — | $4M | -%4.058,0 |
| PALI | PALISADE BIO, INC. | F- | $209,8M | $1,17 | — | $500K | -%8.739,2 |
| RNAC | Cartesian Therapeutics, Inc. | F | $208M | $6,82 | — | $1M | -%12.435,2 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | notsuz | $205,8M | $2,57 | — | — | — |
| HELP | CYBIN INC. | notsuz | $202,8M | $9,39 | — | — | — |
| ARTV | Artiva Biotherapeutics, Inc. | F- | $201,2M | $4,07 | — | $0,00 | — |
| ALPS | ALPS GROUP INC | notsuz | $199,7M | $1,20 | — | — | — |
| OVID | Ovid Therapeutics Inc. | D- | $197,7M | $2,79 | — | $1,5M | -%2.971,3 |
| KRRO | Korro Bio, Inc. | D- | $197,6M | $14,40 | — | $1,3M | -%8.214,5 |
| CGEN | COMPUGEN LTD | B+ | $196,7M | $2,08 | 5,47 | $75,9M | %47,9 |
| LIMN | LIMINATUS PHARMA, INC. | notsuz | $195,8M | $2,92 | — | — | — |
| PYXS | Pyxis Oncology, Inc. | D- | $195M | $1,63 | — | $13,9M | -%625,7 |
| FATE | FATE THERAPEUTICS INC | F- | $194,5M | $1,60 | — | $4,8M | -%2.619,6 |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | $191,2M | $3,24 | — | $0,00 | — |
| ACOG | Alpha Cognition Inc. | D- | $189,8M | $8,72 | — | $15,3M | -%153,6 |
| KROS | KEROS THERAPEUTICS, INC. | F- | $187M | $9,53 | — | $40,8M | -%151,4 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | $185,7M | $1,89 | — | $0,00 | — |
| MDWD | MEDIWOUND LTD. | F- | $177,5M | $13,83 | — | $11,9M | -%170,1 |
| GTBP | GT Biopharma, Inc. | notsuz | $176,8M | $3,92 | 10,59 | — | — |
| IVVD | INVIVYD, INC. | D- | $176,2M | $0,60 | — | $58,4M | -%183,9 |
| SLGL | Sol-Gel Technologies Ltd. | D | $176,1M | $63,20 | — | $1,8M | -%341,3 |
| CURX | Curanex Pharmaceuticals Inc | notsuz | $175,6M | $5,60 | — | — | — |
| UPB | UPSTREAM BIO, INC. | F- | $174,8M | $3,19 | — | $2,9M | -%5.712,3 |
| RNA | Atrium Therapeutics, Inc. | notsuz | $171,7M | $7,96 | — | — | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | $171,6M | $4,13 | — | $2M | %8.743,5 |
| STRO | SUTRO BIOPHARMA, INC. | D | $169,9M | $10,25 | — | $45,1M | -%344,2 |
| ANTX | AN2 Therapeutics, Inc. | notsuz | $169M | $4,46 | — | — | — |
| SION | SIONNA THERAPEUTICS, INC. | notsuz | $167,1M | $3,70 | — | — | — |
| HUMA | Humacyte, Inc. | C- | $165M | $0,59 | — | $2,4M | -%3.955,1 |
| TARA | Protara Therapeutics, Inc. | notsuz | $161,3M | $2,62 | — | — | — |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | notsuz | $160,6M | $23,35 | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | $160,1M | $8,22 | — | $0,00 | — |
| ALXO | ALX ONCOLOGY HOLDINGS INC | notsuz | $154,2M | $1,12 | — | — | — |
| CMPX | COMPASS THERAPEUTICS, INC. | F | $149,5M | $0,83 | — | $0,00 | — |
| IPHA | Innate Pharma SA | F- | $149M | $1,59 | — | $10,1M | -%546,1 |
| MGNX | MACROGENICS, INC. | D- | $148,6M | $2,33 | — | $154,9M | -%33,2 |
| ARMP | ARMATA PHARMACEUTICALS, INC. | notsuz | $141,7M | $3,81 | — | — | — |
| ZURA | Zura Bio Limited | notsuz | $137,7M | $1,43 | — | — | — |
| CUE | Cue Biopharma, Inc. | D- | $137,4M | $18,92 | — | $37,7M | -%435,8 |
| OKUR | ONKURE THERAPEUTICS, INC. | notsuz | $135,5M | $3,35 | — | — | — |
| CLLS | Cellectis S.A. | F- | $135,4M | $1,35 | — | $56,6M | -%115,4 |
| SPRB | Spruce Biosciences, Inc. | F | $133,8M | $46,54 | — | $0,00 | — |
| PRQR | ProQR Therapeutics N.V. | C- | $132,8M | $1,26 | — | $20,5M | -%229,7 |
| ABEO | ABEONA THERAPEUTICS INC. | C- | $130,9M | $2,29 | — | $39M | -%160,3 |
| MENS | Jyong Biotech Ltd. | notsuz | $130,8M | $1,72 | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | $129,8M | $4,50 | — | $40K | -%107.587,6 |
| MOLN | MOLECULAR PARTNERS AG | F | $129,8M | $3,22 | — | $0,00 | — |
| LENZ | LENZ THERAPEUTICS, INC. | F- | $128,8M | $4,10 | — | $12,4M | -%1.135,0 |
| NERV | Minerva Neurosciences, Inc. | notsuz | $127,1M | $2,55 | — | — | — |
| ADAG | Adagene Inc. | C- | $126,2M | $2,13 | — | $7,7M | -%229,6 |
| FHTX | Foghorn Therapeutics Inc. | B | $125,3M | $2,09 | 29,86 | $112,1M | %8,4 |
| IBIO | iBio, Inc. | C- | $124,4M | $0,82 | — | $1,1M | -%3.244,2 |
| ENGN | enGene Therapeutics Inc. | notsuz | $121,3M | $1,81 | — | — | — |
| PYPD | PolyPid Ltd | notsuz | $119,9M | $6,59 | — | — | — |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | $117,4M | $0,48 | — | -$1,2M | %5.253,5 |
| VYGR | Voyager Therapeutics, Inc. | F- | $109,5M | $1,76 | — | $25,1M | -%416,3 |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | $108,3M | $4,37 | — | $194K | -%3.985,6 |
| MSLE | Satellos Bioscience Inc. | notsuz | $107,1M | $6,93 | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | notsuz | $106,7M | $1,34 | — | — | — |
| CDXS | Codexis, Inc. | B- | $106,7M | $0,97 | — | $88,3M | -%21,8 |
| NKTX | Nkarta, Inc. | D | $105,4M | $1,47 | — | $0,00 | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | notsuz | $105M | $3,77 | — | — | — |
| VANI | Vivani Medical, Inc. | F | $100,6M | $1,12 | — | $0,00 | — |
| NBP | NovaBridge Biosciences | notsuz | $99,4M | $0,86 | — | — | — |
| AVXL | ANAVEX LIFE SCIENCES CORP. | notsuz | $97,3M | $1,05 | — | — | — |
| ANIX | ANIXA BIOSCIENCES, INC. | notsuz | $96,6M | $2,78 | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | $96,2M | $1,51 | — | $0,00 | — |
| PMVP | PMV PHARMACEUTICALS, INC. | notsuz | $94,8M | $1,26 | — | — | — |
| PLYX | Polaryx Therapeutics, Inc. | notsuz | $94,7M | $1,90 | — | — | — |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | F | $91,9M | $1,60 | — | $0,00 | — |
| ICCC | ImmuCell Corporation | B | $91,7M | $10,10 | 144,29 | $30,7M | %2,6 |
| CHRS | Coherus Oncology, Inc. | C | $90M | $0,58 | — | $53,6M | -%253,4 |
| LONA | LeonaBio, Inc. | notsuz | $89,4M | $3,77 | — | — | — |
| EQ | EQUILLIUM, INC. | D- | $89,4M | $1,41 | — | $41,1M | -%43,8 |
| SEER | SEER, INC. | F- | $89,3M | $1,60 | — | $14,1M | -%450,9 |
| NMRA | NEUMORA THERAPEUTICS, INC. | notsuz | $88,3M | $0,47 | — | — | — |
| CBUS | Cibus, Inc. | C- | $87,9M | $1,15 | — | $4,5M | -%2.131,4 |
| NRXS | NEURAXIS, INC. | D- | $86,9M | $6,12 | — | $6,5M | -%185,2 |
| GNLX | GENELUX CORPORATION | F- | $86,4M | $1,91 | — | $8K | -%444.950,0 |
| RLYB | RALLYBIO CORPORATION | A | $85,1M | $15,81 | — | $434K | %6.177,4 |
| IFRX | InflaRx N.V. | F- | $84,9M | $1,18 | — | $32,8K | -%155.582,1 |
| TNYA | TENAYA THERAPEUTICS, INC. | notsuz | $84,5M | $0,37 | — | — | — |
| MIST | Milestone Pharmaceuticals Inc. | notsuz | $84,4M | $0,68 | — | — | — |
| ATRA | Atara Biotherapeutics, Inc. | F | $84,2M | $8,26 | — | $4M | -%368,6 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | notsuz | $82,6M | $4,01 | — | — | — |
| JAGX | Jaguar Health, Inc. | C | $82,4M | $0,48 | — | $27,8M | -%132,2 |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | $78,9M | $0,57 | — | $6,6M | -%493,0 |
| TENX | TENAX THERAPEUTICS, INC. | F | $77,2M | $1,70 | — | $0,00 | — |
| TLSA | Tiziana Life Sciences Ltd | notsuz | $76M | $0,63 | — | — | — |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | $74,6M | $3,84 | — | $43M | -%420,4 |
| COYA | Coya Therapeutics, Inc. | F- | $74,6M | $3,18 | — | $4,7M | -%643,5 |
| OKYO | OKYO Pharma Limited | notsuz | $73,7M | $1,41 | — | — | — |
| NTRB | NUTRIBAND INC. | F- | $72,3M | $5,95 | — | $1,6M | -%430,4 |
| GOSS | GOSSAMER BIO, INC. | B | $71,4M | $11,68 | — | $78,4M | -%159,5 |
| MNOV | MEDICINOVA, INC. | C- | $68,9M | $1,40 | — | $920,5K | -%1.168,2 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | D- | $68M | $0,36 | — | $148,2M | -%14,5 |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | $67,9M | $4,88 | — | $60,7M | -%1,8 |
| ACRV | Acrivon Therapeutics, Inc. | notsuz | $67,7M | $1,58 | — | — | — |
| CING | Cingulate Inc. | notsuz | $67,6M | $4,65 | — | — | — |
| CNXU | CONEXEU SCIENCES INC. | notsuz | $67,4M | $2,39 | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | D- | $66,8M | $3,89 | — | $22,9M | -%189,2 |
| CGTX | Cognition Therapeutics, Inc. | notsuz | $64,3M | $0,68 | — | — | — |
| MAIA | MAIA BIOTECHNOLOGY, INC. | notsuz | $64,2M | $1,04 | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | $63,9M | $2,01 | — | $68,5M | %163,3 |
| XLO | Xilio Therapeutics, Inc. | D- | $62,5M | $8,85 | — | $55M | -%20,9 |
| CLNN | Clene Inc. | C | $60,4M | $4,20 | — | $238K | -%11.271,4 |
| SPRO | Spero Therapeutics, Inc. | C | $60M | $1,03 | 7,36 | $47M | %15,7 |
| XBIT | XBiotech Inc. | notsuz | $59,8M | $1,96 | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | $59,6M | $0,77 | — | $559K | -%6.735,2 |
| RNXT | RENOVORX, INC. | D- | $59,3M | $1,23 | — | $2,8M | -%469,0 |
| BOLD | BOUNDLESS BIO, INC. | notsuz | $57,6M | $2,44 | — | — | — |
| PDSB | PDS Biotechnology Corporation | notsuz | $56,5M | $1,01 | — | — | — |
| BCAB | BIOATLA, INC. | notsuz | $56,1M | $1,74 | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | notsuz | $56M | $1,72 | — | — | — |
| INKT | MiNK Therapeutics, Inc. | notsuz | $55,1M | $10,79 | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | $53,3M | $13,20 | 1,57 | $0,00 | — |
| RNTX | Rein Therapeutics, Inc. | F | $52,8M | $0,61 | — | $0,00 | — |
| ONCY | ONCOLYTICS BIOTECH INC. | notsuz | $52,6M | $0,41 | — | — | — |
| AZR | AZORA THERAPEUTICS, INC. | notsuz | $52,4M | $3,67 | — | — | — |
| ATNM | Actinium Pharmaceuticals, Inc. | D+ | $50,9M | $1,62 | 4,50 | $90K | %12.564,4 |
| CLGN | CollPlant Biotechnologies Ltd | D- | $50,7M | $3,96 | — | $318K | -%4.130,2 |
| MREO | MEREO BIOPHARMA GROUP PLC | C | $48,8M | $0,31 | — | $500K | -%5.387,6 |
| GANX | GAIN THERAPEUTICS, INC | notsuz | $48,8M | $1,10 | — | — | — |
| PLRX | PLIANT THERAPEUTICS, INC. | D | $48,3M | $0,78 | — | $0,00 | — |
| HYFT | MindWalk Holdings Corp. | C- | $47,9M | $1,03 | — | $20,1M | -%43,6 |
| HOWL | WEREWOLF THERAPEUTICS, INC. | notsuz | $47,9M | $0,98 | — | — | — |
| IMA | ImageneBio, Inc. | C- | $47,8M | $3,84 | — | $800K | -%5.415,6 |
| DWTX | Dogwood Therapeutics, Inc. | notsuz | $46,3M | $1,21 | — | — | — |
| ELTX | Elicio Therapeutics, Inc. | notsuz | $45,7M | $1,62 | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | notsuz | $45,3M | $1,91 | — | — | — |
| BMEA | Biomea Fusion, Inc. | notsuz | $44,4M | $0,61 | — | — | — |
| BLSM | BlossomHill Therapeutics, Inc. | notsuz | $43,7M | $16,10 | — | — | — |
| TELO | Telomir Pharmaceuticals, Inc. | notsuz | $43,7M | $0,59 | — | — | — |
| CNTB | Connect Biopharma Holdings Limited | C- | $43M | $0,68 | — | $3M | -%2.336,3 |
| TIL | Instil Bio, Inc. | C- | $42,9M | $6,32 | — | $9M | -%337,7 |
| HYPD | HYPERION DEFI, INC. | D+ | $42,3M | $2,73 | — | $1,4M | %474,9 |
| CRBU | Caribou Biosciences, Inc. | F- | $42,1M | $0,39 | — | $9,4M | -%1.085,0 |
| SER | Serina Therapeutics, Inc. | D | $40,9M | $1,54 | — | $260K | -%9.421,5 |
| OSTX | OS THERAPIES INCORPORATED | notsuz | $40,9M | $0,89 | — | — | — |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | $40M | $1,57 | — | $357,9K | -%3.089,6 |
| GRCE | Grace Therapeutics, Inc. | notsuz | $39,5M | $1,88 | — | — | — |
| GRDX | GridAI Technologies Corp. | F- | $39,4M | $5,53 | — | $36,3K | -%56.864,0 |
| ALDX | ALDEYRA THERAPEUTICS, INC. | notsuz | $39,2M | $0,65 | — | — | — |
| EXOZ | EXOZYMES INC. | notsuz | $38,6M | $4,16 | — | — | — |
| IBO | Impact BioMedical, INC. | A | $37,2M | $4,30 | — | $38K | %4.247,4 |
| TVGN | Tevogen Inc. | notsuz | $37M | $5,68 | — | — | — |
| ANVS | Annovis Bio, Inc. | F | $36M | $0,84 | — | $0,00 | — |
| NNVC | NANOVIRICIDES, INC. | F | $35,7M | $1,40 | — | $0,00 | — |
| PTHS | Pelthos Therapeutics Inc. | C- | $35,7M | $9,33 | — | $58,4M | -%133,6 |
| AARD | AARDVARK THERAPEUTICS, INC. | F | $34,8M | $1,59 | — | $0,00 | — |
| INMB | INMUNE BIO INC. | D- | $34,1M | $1,10 | — | $50K | -%33.332,0 |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | notsuz | $33,9M | $0,78 | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | notsuz | $33,9M | $3,78 | — | — | — |
| EYPT | EyePoint, Inc. | F- | $31,5M | $0,37 | — | $2,6M | -%13.281,2 |
| BCTX | BRIACELL THERAPEUTICS CORP. | notsuz | $31,1M | $3,57 | — | — | — |
| SKYE | Skye Bioscience, Inc. | notsuz | $30,3M | $0,86 | — | — | — |
| LITS | Lite Strategy, Inc. | D | $29,2M | $0,98 | — | $0,00 | — |
| NXTC | NextCure, Inc. | notsuz | $28,8M | $6,29 | — | — | — |
| MGX | Metagenomi Therapeutics, Inc. | F- | $28,3M | $0,75 | — | $22,3M | -%421,8 |
| ACET | Adicet Bio, Inc. | notsuz | $27,9M | $2,98 | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | notsuz | $27,8M | $4,07 | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | F- | $27,5M | $2,20 | — | $5,8M | -%1.137,2 |
| ABVC | ABVC BioPharma, Inc. | D- | $26,9M | $1,00 | — | $296K | -%1.322,6 |
| CRVO | CervoMed Inc. | F- | $26,8M | $1,77 | — | $8,7K | -%326.822,5 |
| BYSI | BeyondSpring Inc. | D | $26,4M | $0,64 | — | $0,00 | — |
| IMMP | Immutep Limited | D- | $26,4M | $3,58 | — | $7,3M | -%594,6 |
| BSEM | BioStem Technologies, Inc. | F- | $26,2M | $1,47 | — | $34,6M | -%81,8 |
| ATHE | ALTERITY THERAPEUTICS LTD | notsuz | $24,6M | $2,31 | — | — | — |
| ENLV | Enlivex Ltd. | notsuz | $24,4M | $1,26 | 0,01 | — | — |
| FLNA | Filana Therapeutics, Inc. | notsuz | $24,2M | $0,48 | — | — | — |
| EVAX | Evaxion A/S | B- | $24,2M | $2,90 | — | $7,5M | -%102,4 |
| CELU | Celularity Inc. | D | $24,1M | $0,74 | — | $18,7M | -%245,7 |
| APRE | Aprea Therapeutics, Inc. | notsuz | $23,9M | $0,44 | — | — | — |
| CVM | CEL-SCI CORPORATION | notsuz | $23,1M | $1,32 | — | — | — |
| IGC | IGC PHARMA, INC. | C- | $22,8M | $0,20 | — | $1,3M | -%560,3 |
| EDSA | EDESA BIOTECH, INC. | notsuz | $22,1M | $2,29 | — | — | — |
| NRXP | NRX Pharmaceuticals, Inc. | B | $21,5M | $2,43 | — | $3,4M | -%691,8 |
| ICU | SeaStar Medical Holding Corporation | D- | $21,4M | $1,89 | — | $2,2M | -%678,2 |
| ATOS | ATOSSA THERAPEUTICS, INC. | notsuz | $20,3M | $2,03 | — | — | — |
| APLM | Apollomics Inc. | B | $20,1M | $18,25 | — | $8,5M | -%128,7 |
| COCP | COCRYSTAL PHARMA, INC. | notsuz | $19,9M | $1,04 | — | — | — |
| CNTX | CONTEXT THERAPEUTICS INC. | notsuz | $19,6M | $0,21 | — | — | — |
| KTTA | PASITHEA THERAPEUTICS CORP. | notsuz | $18,4M | $0,55 | — | — | — |
| LPCN | LIPOCINE INC. | D- | $17,7M | $1,60 | — | $3,7M | -%249,2 |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | $17,5M | $1,31 | — | $7,6M | -%344,2 |
| ATYR | ATYR PHARMA, INC. | F- | $17,4M | $6,81 | — | $190K | -%28.065,3 |
| ABOS | Acumen Pharmaceuticals, Inc. | notsuz | $16,9M | $0,23 | — | — | — |
| GOVX | GEOVAX LABS, INC. | F | $15,9M | $2,16 | — | $0,00 | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | $15,8M | $0,95 | — | $3,9M | -%220,5 |
| YARW | YARROW BIOSCIENCE, INC. | D- | $15,5M | $18,10 | — | $482K | -%3.881,5 |
| MCRB | Seres Therapeutics, Inc. | D- | $15,4M | $1,51 | — | $2,1M | -%2.209,6 |
| ALLR | Allarity Therapeutics, Inc. | B- | $15,2M | $0,95 | — | $345K | -%3.575,1 |
| KYNB | KYNTRA BIO, INC. | F | $15,1M | $3,74 | — | $4,6M | %3.967,8 |
| ONCO | Onconetix, Inc. | F- | $14,8M | $3,76 | — | $645,8K | -%1.578,8 |
| PLUR | Pluri Inc. | F | $14,8M | $1,20 | — | $1M | -%2.344,6 |
| BCDA | BioCardia, Inc. | F | $13,9M | $0,92 | — | $0,00 | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | $13,8M | $0,38 | — | $3,8M | -%200,5 |
| BIVI | BIOVIE INC. | notsuz | $13,5M | $1,26 | — | — | — |
| CTXR | Citius Pharmaceuticals, Inc. | notsuz | $13,2M | $0,48 | — | — | — |
| NCEL | NewcelX Ltd. | notsuz | $13,1M | $2,74 | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | $12,6M | $0,19 | — | $7,1M | -%1.618,4 |
| ELAB | PMGC HOLDINGS INC. | D- | $12,5M | $1,54 | — | $2,6M | -%523,0 |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | $12,3M | $6,90 | — | $13,2M | -%63,6 |
| NIKI | Niki BioSolutions, Inc. | notsuz | $12,3M | $1,67 | — | — | — |
| PASG | Passage BIO, Inc. | notsuz | $12,2M | $3,81 | — | — | — |
| KAPA | KAIROS PHARMA, LTD. | notsuz | $12,1M | $0,51 | — | — | — |
| KZIA | Kazia Therapeutics Limited. | F | $12,1M | $7,46 | 6,57 | $29,5K | -%54.287,3 |
| BOLT | Bolt Biotherapeutics, Inc. | F- | $12M | $6,25 | — | $4,7M | -%553,6 |
| CLRB | Cellectar Biosciences, Inc. | notsuz | $11,8M | $1,18 | — | — | — |
| AZTR | Azitra, Inc. | F- | $11,7M | $0,61 | — | $0,00 | — |
| GUTS | Fractyl Health, Inc. | F- | $11,6M | $0,87 | — | $0,00 | — |
| INTS | INTENSITY THERAPEUTICS, INC. | notsuz | $11,2M | $3,38 | — | — | — |
| HIND | VYOME HOLDINGS, INC. | F- | $10,8M | $1,54 | — | $129,7K | -%8.716,8 |
| LSTA | Lisata Therapeutics, Inc. | D- | $10,7M | $1,19 | — | $100K | -%14.621,0 |
| DARE | Dare Bioscience, Inc. | C- | $10,7M | $0,70 | — | $1,4M | -%804,4 |
| ARTL | ARTELO BIOSCIENCES, INC. | notsuz | $10M | $2,18 | — | — | — |
| GDTC | CytoMed Therapeutics Limited | D- | $10M | $0,85 | — | $253,7K | -%1.227,1 |
| CMMB | SNOWDRIFT PARENT CORPORATION | notsuz | $9,9M | $1,38 | — | — | — |
| INAB | IN8BIO, INC. | notsuz | $9,8M | $0,91 | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | $9,7M | $0,82 | — | $3,6M | -%1.055,3 |
| MTVA | METAVIA INC. | notsuz | $9,5M | $1,44 | — | — | — |
| CALC | CalciMedica, Inc. | notsuz | $8,8M | $1,27 | — | — | — |
| AEON | AEON Biopharma, Inc. | notsuz | $8,6M | $0,17 | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | $8,3M | $0,19 | — | $2,5M | -%2.702,6 |
| SNGX | SOLIGENIX, INC. | notsuz | $7,5M | $0,32 | — | — | — |
| TOVX | Theriva Biologics, Inc. | notsuz | $7,4M | $0,16 | — | — | — |
| ACTU | ACTUATE THERAPEUTICS, INC. | notsuz | $7,3M | $0,31 | — | — | — |
| IMRN | IMMURON LIMITED | D- | $7,2M | $0,89 | — | $5,1M | -%71,6 |
| ENVB | ENVERIC BIOSCIENCES, INC. | notsuz | $6,8M | $1,52 | — | — | — |
| ENSC | Ensysce Biosciences, Inc. | D- | $6,8M | $0,35 | — | $4,5M | -%280,5 |
| XCUR | EXICURE, INC. | F | $6,8M | $1,04 | — | $0,00 | — |
| ALZN | ALZAMEND NEURO, INC. | notsuz | $6,4M | $1,34 | — | — | — |
| BLRX | BioLineRx Ltd | C- | $6,4M | $1,48 | — | $1,4M | -%145,5 |
| FBLG | FibroBiologics, Inc. | notsuz | $6,2M | $0,94 | — | — | — |
| LTRN | LANTERN PHARMA INC. | notsuz | $6,2M | $0,49 | — | — | — |
| CNSY | CERENOME, INC. | F- | $6,1M | $0,80 | — | $4,2M | -%620,7 |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | $5,9M | $1,33 | — | $0,00 | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | B- | $5,8M | $1,96 | — | $15,2K | -%42.721,9 |
| TPST | Tempest Therapeutics, Inc. | notsuz | $5,8M | $0,39 | — | — | — |
| CMND | Clearmind Medicine Inc. | notsuz | $5,8M | $4,95 | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | notsuz | $5,6M | $0,88 | — | — | — |
| ACXP | Acurx Pharmaceuticals, Inc. | notsuz | $5,5M | $1,04 | — | — | — |
| PCSA | Processa Pharmaceuticals, Inc. | notsuz | $5,2M | $1,87 | — | — | — |
| PULM | Pulmatrix, Inc. | C- | $5,1M | $1,39 | — | $7,8M | -%51,4 |
| CVKD | Cadrenal Therapeutics, Inc. | notsuz | $4,9M | $1,37 | — | — | — |
| SNTI | Senti Biosciences Holdings, Inc. | F- | $4,9M | $0,16 | — | $55K | -%90.116,4 |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D- | $4,7M | $0,62 | — | $3K | -%249.160,1 |
| IMNN | Imunon, Inc. | notsuz | $4,7M | $0,72 | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | $4,6M | $0,43 | — | $0,00 | — |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | $4,5M | $1,91 | — | $451K | -%1.545,2 |
| AIM | AIM ImmunoTech Inc. | D | $4,5M | $0,15 | — | $95K | -%15.021,1 |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | $4,2M | $1,80 | — | $3,3M | -%75,9 |
| OSRH | OSR HEALTH, INC. | D- | $4,1M | $0,12 | — | $1,8M | -%824,4 |
| TCRT | Alaunos Therapeutics, Inc. | D- | $4,1M | $1,61 | — | $3K | -%133.666,7 |
| PHIO | Phio Pharmaceuticals Corp | notsuz | $4M | $0,84 | — | — | — |
| GRI | GRI BIO, INC. | notsuz | $4M | $1,84 | — | — | — |
| TRAW | Traws Pharma, Inc. | D- | $3,8M | $0,24 | — | $2,8M | -%773,0 |
| AGMB | AgomAb Therapeutics NV | notsuz | $3,8M | $6,93 | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | notsuz | $3,5M | $0,71 | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | $3,5M | $2,81 | — | $36,4K | -%22.448,4 |
| MBIO | MUSTANG BIO, INC. | notsuz | $3,4M | $0,45 | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | notsuz | $3,3M | $1,95 | — | — | — |
| EVGN | EVOGENE LTD. | F | $3,2M | $0,37 | — | $1,3M | -%551,3 |
| SILO | SILO PHARMA, INC. | F- | $2,9M | $1,83 | — | $54,1K | -%8.269,5 |
| REVB | REVELATION BIOSCIENCES, INC. | notsuz | $2,9M | $4,23 | — | — | — |
| VRAX | Virax Biolabs Group Ltd | C- | $2,2M | $0,60 | — | $6,3K | -%95.739,2 |
| SLXN | Silexion Therapeutics Corp | notsuz | $2,2M | $3,23 | — | — | — |
| QNTM | Quantum BioPharma Ltd. | notsuz | $2,2M | $1,95 | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | notsuz | $2M | $1,74 | — | — | — |
| GNPX | Genprex, Inc. | D | $1,8M | $2,25 | — | $0,00 | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | $1,8M | $0,52 | — | $1,1M | -%729,9 |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | $1,8M | $0,51 | — | $3,1M | -%270,9 |
| CLDI | Calidi Biotherapeutics, Inc. | notsuz | $1,7M | $0,68 | — | — | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | $1,7M | $2,21 | — | $21,8K | -%42.206,9 |
| PBM | PSYENCE BIOMEDICAL LTD | notsuz | $1,7M | $3,03 | — | — | — |
| HCWB | HCW Biologics Inc. | B- | $1,7M | $0,91 | — | $6,7M | -%83,8 |
| OGEN | ORAGENICS, INC. | notsuz | $1,6M | $0,36 | — | — | — |
| APVO | Aptevo Therapeutics Inc. | notsuz | $1,4M | $0,76 | — | — | — |
| BDRX | Biodexa Pharmaceuticals PLC | notsuz | $1,3M | $2,44 | — | — | — |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | notsuz | $1,3M | $1,38 | — | — | — |
| CANF | Can-Fite BioPharma Ltd. | F- | $1,3M | $1,57 | — | $405K | -%2.426,7 |
| CRIS | CURIS, INC. | F- | $1,2M | $0,60 | — | $4,3M | -%490,3 |
| BBLG | Bone Biologics Corporation | notsuz | $1,2M | $0,36 | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | notsuz | $903,6K | $0,38 | — | — | — |
| VIVS | VivoSim Labs, Inc. | F | $797,4K | $0,15 | — | $112K | -%11.016,1 |
| HLSQ | BiomX Inc. | notsuz | $739,4K | $0,07 | — | — | — |
| DCOY | Decoy Therapeutics Inc. | notsuz | $710,9K | $1,09 | — | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. | notsuz | $667,8K | $3,80 | — | — | — |
| EDVA | Endovia Health Sciences, Inc. | D | $548,9K | $0,18 | — | $32,1K | -%53.856,5 |
| PLRZ | Polyrizon Ltd. | notsuz | $503,9K | $11,11 | 2,27 | — | — |
| LGVN | LONGEVERON INC. | F- | $449,8K | $3,25 | — | $1,2M | -%1.921,7 |
| VBIO | Valion Bio, Inc. | F- | $435,4K | $0,49 | — | $482K | -%3.890,0 |
| CDT | CDT EQUITY INC. | notsuz | $402,1K | $0,51 | — | — | — |
| SRZN | Surrozen, Inc./DE | D | $374,6K | $31,82 | — | $10,5M | -%3.706,4 |
| SPRC | SCISPARC LTD. | F- | $144,5K | $0,40 | — | $679K | -%1.793,7 |
| NEUP | Neuphoria Therapeutics Inc. | F- | $81,2K | $2,70 | — | $1,2M | -%1.145,7 |
| KALA | KALA BIO, INC. | F | $12,7K | $0,17 | — | $0,00 | — |
| KPTI | Karyopharm Therapeutics Inc. | C | $503,52 | $0,02 | — | $146,6M | -%153,3 |
| PPBT | PURPLE BIOTECH LTD. | notsuz | $331,24 | $1,38 | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | notsuz | — | $13,25 | — | — | — |
| APGE | Apogee Therapeutics, Inc. | notsuz | — | $135,07 | — | — | — |
| ATAI | AtaiBeckley Inc. | notsuz | — | $7,35 | — | $4,1M | -%16.142,0 |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | $0,74 | — | $0,00 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | $84,95 | — | $42,2M | -%1.189,9 |
| ETRA | Electra Therapeutics, Inc. | notsuz | — | $9,42 | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | notsuz | — | $76,99 | — | — | — |
| LNAI | LUNAI BIOWORKS INC. | B | — | $0,16 | — | $52K | -%6.852,0 |
| MLEC | MOOLEC SCIENCE SA | B | — | $0,85 | — | $333,6M | -%52,9 |
| SLBT | SL Science Holding Ltd | notsuz | — | $0,68 | — | — | — |
| TBPH | Theravance Biopharma, Inc. | C | — | $17,03 | — | $104,3M | %51,6 |
| VCRE | Vicore Pharma Holding AB | notsuz | — | $11,03 | — | — | — |
| VRXA | Veraxa Biotech Holding AG | notsuz | — | $1,28 | — | — | — |
| VTVT | vTv Therapeutics Inc. | C- | — | $21,55 | — | $36,8M | -%20,8 |
Temeller SEC belgelerinden, fiyatlar son piyasa verisi taramasından. İstediğiniz sütuna göre sıralayın; rakamı olmayan şirketler her iki yönde de sona düşer.
Piyasa değerine göre büyükten küçüğe sıralı; yeniden sıralamak için herhangi bir sütuna tıklayın. Rakamı olmayan şirketler her iki yönde de sona düşer, çünkü eksik bir F/K ucuzluk değil zarar demektir. Buradaki hiçbir şey bir öneri değildir.